Clinical updates, including trial initiations, enrollment status and data readouts and publications: Polarityte, Scibase.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adrenomed, Aim Immunotech, Algernon, Arcutis, Arena, Arrowhead, Aveo, Eli Lilly, Exicure, Galera, Genelux, Heron, Horizon, Immune-Onc, Knopp, Menarini, Ryvu, Springworks, Verastem, Verona.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biosig, Icad, Immunexpress.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Ampio, Astrazeneca, Blade, Calliditas, Celltrion, Celularity, Corvus, Cyxone, Daiichi Sankyo, Diffusion, Eli Lilly, Humanigen, Inflarx, Kamada, Octapharma, Pfizer, Pharmabcine, Recce, Regeneron, Sinovac, Seneca, Takeda, Verona.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adocia, Aerpio, Arbutus, Atossa, Atyr, Axsome, Clinuvel, Codiak, Curasen, Curevo, Galecto, Kyorin, Marinus, Opko, Teva, TFF, Tyme.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sirtex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89bio, AB Science, Actinium, Alexion, Alzprotect, Astrazeneca, Biontech, Blade, Boehringer, Caelum, Cassava, Celltrion, Cyxone, Daiichi, Diamedica, Diamyd, Enanta, Frequency, Humanigen, Immunity, Incyte, Inflarx, LB, Lilly, Myovant, Novartis, Pfizer, Pharmabcine, Regeneron.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anavex, Aura, Atara, Bicycle, Biogen, Cancer Prevention, Celltrion, Clene, Galapagos, Genentech, GW, Immunic, Lilly, Lyra, Neurocrine, Novartis, Partner, Prothena, Reveragen, Santhera, Voyager.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Avenu Medical, Axonics, Hyperfine, Medifiber, Reshape Lifesciences.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anavex, Arbor, Astrazeneca, Avillion, Bayer, Biohaven, Boehringer Ingelheim, Corcept, Corvus, Diffusion, Forte, Gemini, Haliodx, Histogen, Imcheck, Ocular, Recce, Roche, Sanofi, Satsuma, Seneca, Sobi, Sutro, Takeda, Theratechnologies, VBL, Vertex, Zogenix.